Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.35 |
| ▸ | IL2 | P60568 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15991854 | 0.93 | SMN1; SMN2 (0.33) | SMN1; SMN2TTRIL2TDP1HPGD | |
| SCHEMBL15991882 | 0.87 | SMN1; SMN2 (0.33) | SMN1; SMN2TTRIL2TDP1HPGD | |
| SCHEMBL15991590 | 0.87 | TTR (0.33) | SMN1; SMN2TTRIL2TDP1HPGD | |
| SCHEMBL22692347 | 0.86 | SMN1; SMN2 (0.34) | SMN1; SMN2TTRIL2TDP1HPGD | |
| SCHEMBL15992456 | 0.86 | SMN1; SMN2 (0.34) | SMN1; SMN2TTRIL2TDP1HPGD | |
| SCHEMBL12680320 | 0.85 | ALDH1A1 (0.34) | SMN1; SMN2TTRIL2HPGDKDM4E | |
| SCHEMBL15991811 | 0.85 | SMN1; SMN2 (0.35) | SMN1; SMN2TTRIL2TDP1HPGD | |
| SCHEMBL15991897 | 0.84 | DRD3 (0.36) | SMN1; SMN2TTRIL2HPGDNAMPT | |
| SCHEMBL6849179 | 0.82 | PTGS1 (0.47) | SMN1; SMN2TTRIL2NAMPTNAAA | |
| SCHEMBL2734917 | 0.82 | ALDH1A1 (0.31) | HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2282 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599654-B2 | Immunogenic peptide fragments of metalloprotease ADAMTS-7 and uses thereof in anti-atherosclerosis and related diseases | Beijing Kimway Biotech Co. Ltd (CN) | 2026-04-14 | — | — | US | claimed |
| EP-4719485-A1 | ANTIBODY-DRUG CONJUGATES FOR TREATING INFECTIONS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) | Taimed Biologics Inc. (TW) | 2026-04-08 | — | — | EP | claimed |
| EP-4642491-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | Honeybear Biosciences Inc. (TW) | 2025-11-05 | — | — | EP | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| US-20250177551-A1 | ENGINEERED RED BLOOD CELLS TARGETING PD-1 | WESTLAKE THERAPEUTICS (SHANGHAI) CO., LIMITED (CN) | 2025-06-05 | — | — | US | claimed |
| CN-120060245-A | SiRNA antibody conjugate and application thereof | 佑嘉(杭州)生物医药科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2025055900-A1 | ENGINEERED RED BLOOD CELL FOR SITE-DIRECTED CONJUGATION OF PROTEIN BY MEANS OF CHEMICAL SMALL MOLECULE LINKER | 西湖生物医药科技(上海)有限公司 | 2025-03-20 | — | — | WO | claimed |
| WO-2025027389-A1 | BIOLOGICALLY ACTIVE COMPOUNDS COMPRISING A STAPLED OR STITCHED PEPTIDE | SUTURA THERAPEUTICS LIMITED (GB) | 2025-02-06 | — | — | WO | claimed |
| EP-2848686-B1 | CONJUGATE OF ANTI-CDH3 (P-CADHERIN) ANTIBODY AND DRUG | PERSEUS PROTEOMICS INC (JP) | 2024-12-25 | — | — | EP | claimed |
| US-20240398969-A1 | ANTIBODY-DRUG CONJUGATES FOR TREATING INFECTIONS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) | TAIMED BIOLOGICS INC. (TW) | 2024-12-05 | — | — | US | claimed |
| EP-3404043-B1 | ANTI-CDH3 ANTIBODY HAVING HIGH INTERNALIZATION CAPACITY | PERSEUS PROTEOMICS INC (JP) | 2022-10-26 | — | — | EP | claimed |
| US-11471536-B2 | Process for preparing purified drug conjugates | IMMUNOGEN, INC. (US) | 2022-10-18 | — | — | US | claimed |
| WO-2022204504-A1 | VIRAL VECTORS WITH REDUCED IMMUNOGENICITY | CORNELL UNIVERSITY (US) | 2022-09-29 | — | — | WO | claimed |
| CN-114989637-A | Functionalized zirconia, preparation method thereof and optical film | 山东国瓷功能材料股份有限公司 | 2022-09-02 | — | — | CN | claimed |
| US-20220257789-A1 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | EXELIXIS, INC. | 2022-08-18 | — | — | US | claimed |
| CN-110456074-B | Citrullinated peptide, application thereof, rheumatoid arthritis detection reagent and kit | 广东菲鹏生物有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114573663-A | Citrullinated peptide, application thereof, detection reagent and kit for rheumatoid arthritis | 广东菲鹏生物有限公司 | 2022-06-03 | — | — | CN | claimed |
| US-11332880-B2 | Modifying natural feathers for use in sporting goods | DURABIRD (US) | 2022-05-17 | — | — | US | claimed |
| EP-3994150-A1 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | Iconic Therapeutics, Inc. (US) | 2022-05-11 | — | — | EP | claimed |
| CN-114222752-A | Anti-tissue factor antibody-drug conjugates and related methods | 伊科尼克治疗公司 | 2022-03-22 | — | — | CN | claimed |